Ph.D. Articles
-
What Gives Leucadia Therapeutics an Edge?
Our Chief Executive Office, Doug Ethell, Ph.D., offers a window into our technology and some of our findings in Berlin, Germany, at Undoing Aging 2018. We invite you to listen to the presentation and get excited about Leucadia's present and future! ...
-
Interview: Teisha Rowland, Ph.D., Principal Scientist, Umoja Biopharma
We had the chance to interview Teisha Rowland, Ph.D., Principal Scientist at Umoja Biopharma during the ISSCR in San Francisco about the Umoja/TreeFrog partnership. Leading iPSC engineering at Umoja, she comes back on the vision of Umoja, its RACR™ technology and her interest in TreeFrog’s C-Stem™ platform for the development of iPSC-derived allogeneic products in ...
-
Richard E. Engler, Ph.D. Interviewed In Nature Biotechnology Article “A face-lift for biotech rules
The December 2015 issue of Nature Biotechnology included comments by Richard E. Engler, Ph.D. on keeping biotech rules current with scientific progress in the article “A face-lift for biotech rules begins.” To stay up to date with technology, Richard Engler, a senior chemist at the environmental law firm Bergeson & Campbell in Washington, DC, suggested that technology stewards be ...
-
Navigating Cancer Announces New Appointment to Board of Directors
Navigating Cancer announced today that Alexandra Snyder, MD, Chief Medical Officer at Generate Biomedicines, has agreed to join its board of directors. Dr. Snyder is succeeding David M. Rubin, Ph.D. who served on Navigating Cancer’s Board from 2015 to the present. “We are pleased to welcome Dr. Snyder to Navigating Cancer’s Board and especially value her point of view as a ...
-
Aelan Cell Technologies Adds Human Embryonic Stem Cell Expert Meenakshi Gaur, Ph.D. to Stem Cell Clinical Program
SAN FRANCISCO, CA--(Marketwired - Sep 11, 2015) - Aelan Cell Technologies announced today the addition of Meenakshi Gaur, Ph.D. to their stem cell clinical program. Dr. Gaur will serve as the Director of Research and Development of the Stem Cell Program, leading a research team that will develop technology aimed at rejuvenation of human mesenchymal stem cells for clinical applications. "Dr. Gaur ...
-
Introducing Navigating Cancer’s Medical Advisory Board Ahead of ASCO Presentations Illustrating Equitable Cancer Care Innovation
Navigating Cancer is filling an important role in the healthcare community during a time that has placed tremendous pressure on healthcare providers to better support a growing and diverse patient population, outside-of-the-clinic. Digital health tools and remote symptom monitoring enable more efficient care delivery and improve patient outcomes – while providing actionable insights based ...
-
A Conversation with Prof. Davide Capodanno, M.D., Ph.D. on the Landmark TAILOR-PCI Clinical Trial Results
After seven years and 5,300-patients tested, the results of the landmark TAILOR-PCI trial were announced in a virtual ACC session. This trial investigated whether a prospective approach using rapid on-site CYP2C19 testing could improve patient outcomes when selecting P2Y12 inhibitor therapy following PCI procedure. This is based on the well-established evidence that approximately 30-50% of ...
By Genomadix
-
How Dr. Yamina Berchiche uses Genemod’s platform to accurately record and organize her sample info
Dr. Yamina Berchiche is a Biochemistry Ph.D. from Canada with over 10 years of experience leading multiple R&D projects in startup, government, and academic environments. She has spent 20 years working in laboratory environments focused on multi-span proteins called GPCRs: the largest family of membrane proteins that are involved in many disease modalities including immune disorders. ...
-
Creating a Natural Microenvironment for Culturing Islet Cells
Type 1 diabetes is an autoimmune disease that leads to destruction of pancreatic islet cells. For many years, islet transplantation has been the focus of intense investigation as an insulin replacement therapy. Although transplantation immediately achieves insulin independence, the natural ability to continue producing insulin all but disappears 5 years later. There are many problems with ...
-
Mid-Size Laboratories Can Now Enjoy the Same Efficiency Benefits as Large Facilities with Beckman Coulter’s New Hematology Analyzer
Beckman Coulter , a global leader in clinical diagnostics, today announced the commercial launch of its new DxH 690T hematology analyzer. Designed to help laboratories streamline workflow and maximize uptime, the DxH 690T offers all the benefits of the company’s flagship DxH 900 hematology analyzer to mid-size labs, including an industry-leading 93% first-pass yield and the recently ...
-
mRNA vaccine for the pregnant produces antibodies that are passed on to the child and remain for at least 6 months
As the COVID-19 pandemic enters its third year, efforts to mitigate the risk of infection remain critical, especially for vulnerable populations. Recently, Andrea Edlow et al. of Massachusetts General Hospital published a study in the journal JAMA entitled "Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection". The study showed that ...
-
Enabling Genomics in Practice
There are certain times in your life where a single sentence can change your life’s trajectory. My sentence was, “Theo has leukemia.” For anyone who has experienced it, they know far too well that cancer spares no one. While the warriors like my nephew bravely battle, it uproots entire families. Time is divided between hospital and home, and normalcy no longer exists. ...
By PierianDx
-
Nanostics Receives CE Mark for its ClarityDX Prostate Test to Detect Clinically Significant Prostate Cancer
Nanostics’ biomarker and machine learning-powered test, ClarityDX Prostate®, received a CE-IVD Mark. A CE-IVD Mark is required for all in vitro diagnostic (IVD) devices to be placed in the European Economic Area, Iceland, Norway, and Liechtenstein and allows Nanostics to market and sell ClarityDX Prostate® in these countries. The ClarityDX Prostate® test provides patients ...
-
Algatech Triples FucoVital Production Capacity
Fucovital is the first tiver health support extract derived from microalgae Kibbutz Ketura, Israel—Algatechnologies, Ltd. ("Algatech") announces it has tripled its production capacity for FucoVital .The action follows increased demand from the dietary supplements market. FucoVital was launched in the U.S. in 2018. Algatech's Fucovital proprietary fucoxanthin oleoresin is the world's ...
By Algatech
-
Standards in Capstone Projects
My standards education began in 1990 when I became the chairman of an ASTM International task group. I was the group leader of R&D for a medical device manufacturer, recognized the need for a specific industry standard and felt that taking a leadership role in developing this standard would be a good professional development activity. The standard was eventually approved and I continue to ...
-
N95 Mask Material Inventor and AFS Fellow Peter Tsai Exits Retirement to Join Covid-19 Response
Long-time AFS member and supporter Peter Tsai has recently received international attention for coming out of retirement to join the battle against Covid-19. As the inventor of the synthetic fabric used to make the N95 mask that is critical in protecting front-line healthcare workers and stemming the spread of coronavirus, Peter started receiving a barrage of requests in mid-March for his ...
-
Treos Bio Announces the Publication of Preclinical Data in Frontiers in Genetics Showing its COVID-19 Peptide Vaccine Mimics the Diversity of T Cell Immunity Produced by Natural SARS-CoV-2 Infection
LONDON, June 28, 2021 (GLOBE NEWSWIRE) – Treos Bio Limited (“Treos”), a clinical stage biotechnology company using data science and proprietary biomarkers to develop precision off-the-shelf and personalized peptide cancer immunotherapies, today announced the publication of a peer-reviewed article titled “A Peptide Vaccine Candidate Tailored to Individuals’ Genetics ...
-
The Major Breakthrough That Completely Stopped This Woman`s Painful Genital Herpes Outbreaks
In the span of seven days, Mel Smith left her verbally abusive boyfriend, moved out of their house with her 13-year-old son, and found out that she had contracted genital herpes. “I didn’t know what it was. I didn’t know what to do,” she says, remembering the time five years ago when her vagina itched so badly she couldn’t wear underwear. Her diagnosis? Herpes ...
-
Entrepreneur in Residence
Celdara Medical, LLC (CM) is developing a portfolio of preclinical therapeutic assets, platforms, and companies. Each of these has a different development path, and we work with many different modalities, and in many different indications, but everything we do is singularly focused on saving lives and/or improving quality of life. The successful Entrepreneur In Residence will identify one or ...
-
The Medical University of South Carolina - Case study
Medical University of South Carolina (MUSC) is South Carolina’s only comprehensive academic health science center. Its purpose is to preserve and optimize human life in South Carolina through the vision to lead health innovation for the lives it touches. Ludivine Renaud has a Bachelor’s degree in marine biology from the College of Charleston, a Master’s degree in environmental ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you